Biology of IL-21 and the IL-21 receptor

被引:161
作者
Mehta, DS
Wurster, AL
Grusby, MJ
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
关键词
D O I
10.1111/j.0105-2896.2004.00201.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin-21 (IL-21) is the newest member of the common gamma-chain family of cytokines, which includes IL-2, IL-4, IL-7, IL-9, IL-13, and IL-15. Its private receptor, IL-21R, has been shown to activate the Janus kinase/signal transducers and activators of transcription signaling pathway upon ligand binding. Initial studies have demonstrated that IL-21 has pleiotropic effects on the proliferation, differentiation, and effector functions of B, T, natural killer, and dendritic cells. More recently, the potential therapeutic capacity of IL-21 in the treatment of cancers has been widely investigated. The biological role of IL-21 in the immune system is complex, as IL-21 has been shown to have the ability to both promote and inhibit immune responses. Overall, the current data point to IL-21 being a novel immunomodulatory cytokine, whose regulation of any given immune response is highly dependent on the surrounding environmental context.
引用
收藏
页码:84 / 95
页数:12
相关论文
共 56 条
[1]   Cutting edge:: The common γ-chain is an indispensable subunit of the IL-21 receptor complex [J].
Asao, H ;
Okuyama, C ;
Kumaki, S ;
Ishii, N ;
Tsuchiya, S ;
Foster, D ;
Sugamura, K .
JOURNAL OF IMMUNOLOGY, 2001, 167 (01) :1-5
[2]   Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: Attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses [J].
Bennett, F ;
Luxenberg, D ;
Ling, V ;
Wang, IM ;
Marquette, K ;
Lowe, D ;
Khan, N ;
Veldman, G ;
Jacobs, KA ;
Valge-Archer, VE ;
Collins, M ;
Carreno, BM .
JOURNAL OF IMMUNOLOGY, 2003, 170 (02) :711-718
[3]   IL-21 induces the functional maturation of murine NK cells [J].
Brady, J ;
Hayakawa, Y ;
Smyth, MJ ;
Nutt, SL .
JOURNAL OF IMMUNOLOGY, 2004, 172 (04) :2048-2058
[4]   Interleukin-21 inhibits dendritic cell activation and maturation [J].
Brandt, K ;
Bulfone-Paus, S ;
Foster, DC ;
Rückert, R .
BLOOD, 2003, 102 (12) :4090-4098
[5]   Interleukin-21 inhibits dendritic cell-mediated t cell activation and induction of contact hypersensitivity in vivo [J].
Brandt, K ;
Bulfone-Paus, S ;
Jenckel, A ;
Foster, DC ;
Paus, R ;
Rückert, R .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 121 (06) :1379-1382
[6]   Interleukin-21 is a growth and survival factor for human myeloma cells [J].
Brenne, AT ;
Ro, TB ;
Waage, A ;
Sundan, A ;
Borset, M ;
Hjorth-Hansen, H .
BLOOD, 2002, 99 (10) :3756-3762
[7]   STAT proteins:: From normal control of cellular events to tumorigenesis [J].
Calò, V ;
Migliavacca, M ;
Bazan, V ;
Macaluso, M ;
Buscemi, M ;
Gebbia, N ;
Russo, A .
JOURNAL OF CELLULAR PHYSIOLOGY, 2003, 197 (02) :157-168
[8]   DEFECTIVE LYMPHOID DEVELOPMENT IN MICE LACKING EXPRESSION OF THE COMMON CYTOKINE RECEPTOR-GAMMA CHAIN [J].
CAO, XQ ;
SHORES, EW ;
HULI, J ;
ANVER, MR ;
KELSALL, BL ;
RUSSELL, SM ;
DRAGO, J ;
NOGUCHI, M ;
GRINBERG, A ;
BLOOM, ET ;
PAUL, WE ;
KATZ, SI ;
LOVE, PE ;
LEONARD, WJ .
IMMUNITY, 1995, 2 (03) :223-238
[9]   IL-21 and IL-21 receptor - A new cytokine pathway modulates innate and adaptive immunity [J].
Collins, M ;
Whitters, MJ ;
Young, DA .
IMMUNOLOGIC RESEARCH, 2003, 28 (02) :131-140
[10]   IL-21 induces tumor rejection by specific CTL and IFN-γ-dependent CXC chemokines in syngeneic mice [J].
Di Carlo, E ;
Comes, A ;
Orengo, AM ;
Rosso, O ;
Meazza, R ;
Musiani, P ;
Colombo, MP ;
Ferrini, S .
JOURNAL OF IMMUNOLOGY, 2004, 172 (03) :1540-1547